GLOBAL INDUCED PLURIPOTENT STEM CELLS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Global Induced Pluripotent Stem Cells Market, By Cell Source (Skin derived iPSCs, Blood derived iPSCs, Urine Derived iPSCs, Hepatocytes derived iPSCs, Lung fibroblast derived iPSCs and Others), By Application (Culture & Maintenance, Differentiation, Genetic Manipulation & Engineering, Characterization & Validation, Banking & Storage and Others), By End User (Hospitals, Diagnostics Centers, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Recent Developments

Facility Expansion

In 2022, Century Therapeutics, a pharmaceutical company and Bristol Myers Squibb, a global biopharmaceutical company entered into a research collaboration and license agreement in order to develop and commercialize up to four induced pluripotent stem cell derived, engineered natural killer cell and / or T cell programs for hematologic malignancies and solid tumors. The first two programs include a program in acute myeloid leukemia and a program in multiple myeloma, which could incorporate either the iNK or a gamma delta iT platform. Bristol Myers Squibb has the option to add two additional programs which can be nominated subject to certain conditions agreed with Century Therapeutics in the agreement.
In 2022, Promega Corporation, one of the leaders in providing innovative solutions and technical support to the life sciences industry, and FUJIFILM Cellular Dynamics, Inc., a leading global developer and manufacturer of human induced pluripotent stem cell (iPSC) technologies, entered into a strategic collaboration in order to advance novel assay development for drug discovery. Under a multi-year licensing agreement, FUJIFILM Cellular Dynamics will offer a wide range of custom differentiated iPSCs integrated with Promega Corporation biosensor and intracellular bioluminescent reporter capabilities for researchers and scientists to use as part of novel assay development in the drug discovery process.